Pressreleases

Rhenovia Signs Two-Year EUR 500,000 Partnership with AFM to Support its Simulation Technology for Diseases of the Nervous System

This strategic agreement will help accelerate development of Rhenovia’s unique technology and enable AFM to explore new avenues for the treatment of neurological diseases.

Rhenovia Signs an R&D Contract with Sodiaal-Candia for Studying the Nutritional and Therapeutic Value of Milk and Its Derivatives

Strategic contract will enable Rhenovia to apply its pharmaceutical research know-how to develop activities in the health food and supplements market.

QUMAS Launches ComplianceSP on Microsoft SharePoint 2010

QUMAS, the leading provider of Compliance Solutions to highly regulated industries, today announced the launch QUMAS ComplianceSP on Microsoft SharePoint 2010. QUMAS ComplianceSP is an innovative document and quality management solution, combining the power of SharePoint 2010 with the regulatory domain expertise that QUMAS has proven over 17 years of providing core compliance solutions to regulated industries.

QUMAS Achieves Microsoft Gold Partnership

QUMAS, the leading provider of Compliance Solutions to highly regulated companies, has announced the achievement of the Gold Content Management competency in the Microsoft Partner Network, demonstrating its ability to meet evolving customer needs in today’s dynamic business environment. To earn a Microsoft Gold competency, organizations must complete a rigorous set of tests to prove their level of technology expertise, have the right number of Microsoft Certified Professionals, submit customer references and demonstrate their commitment to customer satisfaction.

Screening Compound Resynthesis Services from Chemonaut and iThemba Pharmaceuticals

iThemba Pharmaceuticals and Chemonaut announce a collaboration on providing a screening compound re-synthesis service. The collaboration has stemmed from both companies recognising that in the dynamically changing world of screening compound supply, it has become more difficult to resource hit compounds from their original source.

Randox Pharma Services pushes the Boundaries of Biomarker Discovery

Randox has been supplying the world’s leading CRO’s, Pharmaceutical and Biotech companies for nearly three decades, and has unrivalled in-house technical know-how, whether in the development of new biomarker assays, companion diagnostics or the manufacture of the highest quality clinical diagnostic reagents.

XMV – a Smart Pharmaceutical Solution in the Fight Against Counterfeiting

METTLER TOLEDO Garvens announces the launched of its newest ground-breaking and innovative pharmaceutical serialisation solution which is already being praised by leading pharmaceutical companies as one of the best systems available in the fight against product counterfeiting.

Pharmaceutical Serialisation Set New Standards

METTLER TOLEDO Garvens announces the launch of its newest pharmaceutical serialisation and weighing combination solution the XS2 MV (Mark and Vision) system. This new system was developed in close co-operation with world leading pharmaceutical companies to offer a solution with such a high degree of operational flexibility that it offers over 375 standard configurations.

Medpace Continues their European Expansion with the Acquisition of Medical Consulting Dr Schlichtiger

Medpace, Inc. continues their European expansion with the acquisition of Medical Consulting Dr. Schlichtiger GmbH, a European CRO with key expertise in drug development and special focus on regulatory consulting and drug safety.